Gores Holdings VII, Inc. (GSEVU) Prices Upsized $480M IPO
Gores Holdings VII, Inc. announced the pricing of its upsized $480 million IPO this morning and its units are expected to begin trading on the Nasdaq under the symbol “GSEVU,” Tuesday, February 23.
...READ MORE
Arctos NorthStar Acquisition Corp. (ANAC.U) Prices $275M IPO
Arctos NorthStar Acquisition Corp. announced the pricing of its $275 million IPO this evening and its units are expected to begin trading on the NYSE under the symbol “ANAC.U,” Tuesday, February 23.
...READ MORE
CM Life Sciences II Inc. (CMIIU) Prices Upsized $240M IPO
CM Life Sciences II Inc. announced the pricing of its upsized $240 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “CMIIU,” Tuesday, February 23.
...READ MORE
Velocity Acquisition Corp. (VELOU) Prices $200M IPO
Velocity Acquisition Corp. announced the pricing of its $200 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “VELOU,” Tuesday, February 23.
...READ MORE
FTAC Athena Acquisition Corp. (FTAAU) Prices $220M IPO
FTAC Athena Acquisition Corp. announced the pricing of its $220 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “FTAAU,” Tuesday, February 23.
...READ MORE
Slam Corp. (SLAMU) Prices $500M IPO
Slam Corp. announced the pricing of its $500 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “SLAMU,” Tuesday, February 23.
...READ MORE
Rodgers Silicon Valley Acquisition Corp (RSVA) to Combine with Enovix Corporation in $1.128Bn Deal
Rodgers Silicon Valley Acquisition Corp (NASDAQ:RSVA) has entered into a definitive agreement to combine with Enovix Corporation, a designer and manufacturer of next generation 3D Silicon™ Lithium-ion batteries, for an implied enterprise value of $1.128 billion, representing 1.41x estimated 2025 Revenue.
...READ MORE
Risky Business: Protecting your de-SPAC Transaction
As merger and acquisition activity heats up, SPACs can use insurance to safeguard their investments against target liabilities that emerge following a de-SPAC transaction.
Mike Blankenship, Partner, Capital Markets, Winston Strawn
Andrew Pelzer, Practice Leader, Transaction Advisory Practice, NFP
Andrew Pendergast, SPAC Practice Leader, NFP
Protecting SPAC Investment
SPACs are completing IPOs at a record pace.
...READ MORE
Figure Acquisition Corp. I (FACA.U) Prices $250M IPO
Figure Acquisition Corp. I announced the pricing of its $250 million IPO this evening and its units are expected to begin trading on the NYSE under the symbol “FACA.U,” Friday, February 19.
...READ MORE
Osprey Technology Acquisition Corp. (SFTW) to Combine with BlackSky in $1.1Bn Deal
Osprey Technology Acquisition Corp. (“SFTW”) announced this morning that it had entered into a definitive agreement to combine with satellite imaging company BlackSky Holdings, Inc. (“BlackSky”) at an enterprise value of $1.106 billion. Founded in 2014, Herndon V.A. based BlackSky is a a real-time Earth observation company leveraging the innovative performance and economics of smallRead More
Collective Growth Corp. (CGRO) & Innoviz: Live Q&A
A
Live Management Presentation and Q&A
Please join
Collective Growth Corp. (CGRO)
&
Innoviz Technologies, Ltd.
for an online investor presentation and live Q&A discussion regarding their proposed merger, featuring:
Co-founder and CEO: Omer Keilaf
Co-founder & Chief Business Officer: Oren Rosenzweig
Chief Financial Officer: Eldar Cegla
Date: Wednesday, February 24th
Time: 1:00 p.m.
...READ MORE 
Alpha Healthcare Acquisition Corp. (AHAC) to Combine with Humacyte in $849Mn Deal
Alpha Healthcare Acquisition Corp. (“AHAC”) announced this morning that it had entered into a definitive agreement to combine with biotech company Humacyte, Inc. (“Humacyte”) at an enterprise value of $849 million. Durham N.C. based Humacyte is a a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. The combined company isRead More
FG New America (FGNA) to Combine with OppFi in $900Mn Deal
FG New America Acquisition Corp. (FGNA) announced this morning that it had entered into a definitive agreement to combine with fintech lender Opportunity Financial (OppFi) at an enterprise value of $909 million. Chicago-based OppFi provides short-term credit to underbanked borrowers, having processed about 1.5 million loans to about 594,000 customers to date. The combined companyRead More
CM Life Sciences (CMLF) to Combine with Sema4 in $2.1Bn Deal
CM Life Sciences (CMLF) announced this morning that it had entered into a definitive business combination agreement with Sema4, an AI and machine learning-driven patient-centered genomic and clinical data intelligence company. Founded in 2016, Sema4 is dedicated to transforming healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting inRead More
Pivotal Investment Corp. III (PICC.U) Prices Upsized $240M IPO
Pivotal Investment Corp. III announced the pricing of its upsized $240 million IPO this evening and its units are expected to begin trading on the NYSE under the symbol “PICC.U” Tuesday, February 9.
...READ MORE
ECP Environmental Growth Opportunities Corp. (ENNVU) Prices $300M IPO
ECP Environmental Growth Opportunities Corp. announced the pricing of its $300 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “ENNVU” Tuesday, February 9.
...READ MORE
Venus Acquisition Corp. (VENAU) Prices $40M IPO
Venus Acquisition Corp. announced the pricing of its $40 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “VENAU” Tuesday, February 9.
...READ MORE
ARYA Sciences Acquisition Corp. III (ARYA) to Combine with Nautilus Biotechnology in $905M Deal
ARYA Sciences Acquisition Corp. III (Nasdaq:ARYA) has entered into a definitive agreement to combine with Nautilus Biotechnology, Inc. for an enterprise value of $905 million. Nautilus is working to create a machine-learning technology platform for testing and mapping proteins and serve as an accelerant in biopharmaceutical research. The combined entity is expected to trade onRead More
Thunder Bridge Capital Partners III Inc. (TBCPU) Prices Upsized $360M IPO
Thunder Bridge Capital Partners III Inc. announced the pricing of its upsized $360 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “TBCPU” Friday, February 5.
...READ MORE